Interleukin-4 augments acetylated LDL-induced cholesterol esterification in macrophages

Journal of Lipid Research

Volumn 41, Issue 3, 2000, Pages 376-383

  Cornicelli, Joseph A ^a   Butteiger, Dustie ^b   Rateri, Debra L ^b   Welch, Kathryn ^a   Daugherty, Alan ^b  

^a Parke Davis ^*  (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

VLDL; CD36; Cytokines; LDL; Scavenger receptor

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; FUCOIDIN; INTERLEUKIN 4; LOW DENSITY LIPOPROTEIN; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; BINDING SITE; CELL SURFACE; CHOLESTEROL ESTERIFICATION; CONTROLLED STUDY; LIPID METABOLISM; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL LINE; CHOLESTEROL; ESTERIFICATION; INTERLEUKIN-4; LIPOPROTEINS, LDL; MACROPHAGES, PERITONEAL; MALE; MICE;

EID: 0034033875     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Tabas, I. 1999. Nonoxidative modifications of lipoproteins in atherogenesis. Ann. Rev. Nutr. 19: 123-139.
2. Chisolm, G. M., S. L. Hazen, P. L. Fox, and M. K. Cathcart. 1999. The oxidation of lipoproteins by monocytes-macrophages - Biochemical and biological mechanisms. J. Biol. Chem. 274: 25959-25962.
3. Krieger, M., S. Acton, J. Ashkenas, A. Pearson, M. Penman, and D. Resnick. 1993. Molecular flypaper, host defense, and atherosclerosis - structure, binding properties, and functions of macrophage scavenger receptors. J. Biol. Chem. 268: 4569-4572.
4. Basu, S. K., J. I., Goldstein, R. G. W. Anderson, and M. S. Brown. 1976. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc. Natl. Acad. Sci. USA. 73: 3178-3182.
5. Kodama, T., M. Freeman, L. Rohrer, J. Zabrecky, P. Matsudaira, and M. Krieger. 1990. Type I macrophage scavenger receptor contains α-helical and collagen-like coiled cells. Nature. 343: 531-535.
6. Rohrer, L., M. Freeman, T. Kodama, M. Penman, and M. Krieger, 1990. Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature. 343: 570-572.
7. Gough, P. J., D. R. Greaves, and S. Gordon. 1998. A naturally occurring isoform of the human macrophage scavenger receptor (SR-A) gene generated by alternative splicing blocks modified LDL uptake. J. Lipid Res. 39: 531-543.
8. Krieger, M., and J. Herz. 1994. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63: 601-637.
9. Stanton, L. W., K. T. White, C. M. Brayant, A. A. Protter, and G. Endemann. 1992. A macrophage Fc receptor for IgI is also a receptor for oxidized low density lipoprotein. J. Biol. Chem. 267: 22446-22451.
10. Endemann, G., L. W. Stanton, K. S. Madden, C. M. Brayant, R. T. White, and A. A. Potter. 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268: 11811-11816.
11. Acton, S., A. Rigotti, K. T. Landschulz, S. Z. Xu, H. H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271: 518-520.
12. Elomaa, O., M. Kangas, C. Sahlberg, J. Tuukkanen, R. Sormunen, A. Liakka, I. Thesleff, G. Kraal, and K. Tryggvason. 1995. Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell. 80: 603-609.
13. Ramprasad, M. P., V. Terpstra, N. Kondratenko, O. Quehenberger, and D. Steinberg. 1996. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA. 93: 14833-14838.
14. Sawamura, T., N. Kume, T. Aoyama, H. Moriwaki, H. Hoshikawa, Y. Aiba, T. Tanaka, S. Miwa, Y. Katsura, T. Kita, and T. Masaki. 1997. An endothelial receptor for oxidized low-density lipoprotein. Nature. 386: 73-77.
15. Suzuki, H., Y. Kurihara, M. Takeya, N. Kamada, M. Kataoka, K. Jishage, O. Ueda, H. Sakaguchi, T. Higashi, T. Suzuki, Y. Takashima, Y. Kawabe, O. Cynshi, Y. Wada, M. Honda, H. Kurihara, H. Aburatani, T. Doi, A. Matsumoto, S. Azuma, T. Noda, Y. Toyoda, H. Itakura, Y. Yazaki, S. Horiuchi, K. Takahashi, J. K. Kruijt, T. J. C. van Berkel, U. P. Steinbrecher, S. Ishibashi, N. Maeda, S. Gordon, and T. Kodama. 1997. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 386: 292-296.
16. Sakaguchi, H., M. Takeya, H. Suzuki, H. Hakamata, T. Kodama, S. Horiuchi, S. Gordon, L. J. W. van der Laan, G. Kraal, S. Ishibashi, N. Kitamura, and K. Takahashi. 1998. Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice. Lab. Invest. 78: 423-434.
17. Daugherty, A., and S. E. Roselaar. 1995. Lipoprotein oxidation as a mediator of atherogenesis: insights from pharmacological studies. Cardiovasc. Res. 29: 297-311.
18. Hansson, G. K., J. Holm, and L. Jonasson. 1989. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135: 169-175.
19. van der Wal, A. C., J. J. Pick, O. J. de Boer, K. T. Koch, P. Teeling, C. M. van der Loos, and A. E. Becker. 1998. Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart. 80: 14-18.
20. Kishikawa, H., T. Shimokama, and T. Watanabe. 1993. Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis. Virchows Archiv. A Pathol. Anat. 423: 433-442.
21. Salomon, R. N., R. Underwood, M. V. Doyle, A. Wang, and P. Libby. 1992. Increased apolipoprotein-E and c-fms gene expression without elevated interleukin-1 or interleukin-6 messenger RNA levels indicates selective activation of macrophage functions in advanced human atheroma. Proc. Natl. Acad. Sci. USA. 89: 2814-2818.
22. Geng, Y. J., and G. K. Hansson. 1992. Interferon-γ inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J. Clin. Invest. 89: 1322-1330.
23. Fong, L. G., T. A. T. Fong, and A. D. Cooper. 1990. Inhibition of mouse macrophage degradation of acetyl low density lipoprotein by interferon-γ. J. Biol. Chem. 265: 11751 -11760.
24. Lopes-Virella, M. F., R. L. Klein, and H. C. Stevenson. 1987. Low density lipoprotein metabolism in human macrophages stimulated with microbial or microbial-related products. Arteriosclerosis. 7: 176-184.
25. de Whalley, C. V., and D. W. H. Riches. 1991. Influence of the cytocidal macrophage phenotype on the degradation of acetylated low density lipoproteins-dual regulation of scavenger receptor activity and of intracellular degradation of endocytosed ligand. Exp. Cell Res. 192: 460-468.
26. Gupta, S., A. M. Pablo, X. C. Jiang, N. Wang, A. R. Tall, and C. Schindler. 1997. IFN-γ potentiates atherosclerosis in apoE knockout mice. J. Clin. Invest. 99: 2752-2761.
27. Kovanen, P. T., M. Kaartinen, and T. Paavonen. 1995. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation. 92: 1084-1088.
28. Doyle, A. G., G. Herbein, L. J. Montaner, A. J. Minty, D. Caput, P. Ferrara, and S. Gordon. 1994. Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-γ. Eur. J. Immunol. 24: 1441-1445.
29. Nicoletti, A., S. Kaveri, G. Caligiuri, J. Bariety, and G. K. Hansson. 1998. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin. Invest. 102: 910-918.
30. Sasaguri, T., N. Arima, A. Tanimoto, S. Shimajiri, T. Hamada, and Y. Sasaguri. 1998. A role for intrrleukin 4 in production of matrix metalloproteinase 1 by human aortic smooth muscle cells. Atherosclerosis. 138: 247-253.
31. Stemme, S., B. Faber, J. Holm, O. Wiklund, J. L. Witztum, and G. K. Hansson. 1995. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA. 92: 3893-3897.
32. Gornicelli, J. A., K. Welch, B. Auerbach, S. J. Feinmark, and A. Daugherty. 1996. Mouse peritoneal macrophages contain abundant ω-6 lipoxygenase activity that is independent of interleukin-4. Arterioscler. Thromb. Vasc. Biol. 16: 1488-1494.
33. Nakagawara, A., and C. F. Nathan. 1983. A simple method for counting adherent cells: application to cultured human monocytes, macrophages and multinucleated giant cells. J. Immunol. Mehods. 56: 261-268.
34. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
35. 125I-dilactitol tyramine. J. Biol. Chem. 260: 14564-14570.
36. Brown, M. S., J. L. Goldstein, M. Krieger, Y. K. Ho, and R. G. W. Anderson. 1979. Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins. J. Cell Biol. 82: 597-613.
37. Sendobry, S. M., J. A. Cornicelli, K. Welch, M. J. Grusby, and A. Daugherty. 1998. Absence of T lymphocyte-derived cytokines fails to diminish macrophage 12/15-lipoxygenase expression in vivo. J. Immunol. 161: 1477-1482.
38. Conrad, D. J., H. Kuhn, M. Mulkins, E. Highland, and E. Sigal. 1992. Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc. Natl. Acad. Sci. USA. 89: 217-221.
39. Nassar, G. M., J. D. Morrow, L. J. Roberts, F. G. Lakkis, and K. F. Badr. 1994. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J. Biol. Chem. 269: 27631-27634.
40. Benz, D. J., M. Mol, M. Ezaki, N. Moriito, I. Zelan, A. Miyanohara, T. Friedmann, S. Parthasarathy, D. Steinberg, and J. L. Witztum. 1995. Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblasts expressing high levels of human 15-lipoxygenase. J. Biol. Chem. 270: 5191-5197.
41. Van der Kooij, M. A., O. H. Morand, H. J. Kempen, and T. J. C. van Berkel. 1996. Decrease in scavenger receptor expression in human monocyte-derived macrophages treated with granulocyte macrophage colony-stimulating factor. Arterioscler. Thromb. Vasc. Biol. 16: 106-114.
42. van Lenten, B. J. and A. M. Fogelman. 1992. Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-alpha. J. Immunol. 148: 112-116.
43. Hsu, H. Y., A. C. Nicholson, and D. P. Hajjar. 1996. Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-α is transcriptionally and post-transcriptionally regulated. J. Biol. Chem. 271: 7767-7773.
44. Bottalico, L. A., R. E. Wager, L. B. Agellon, R. K. Assoian, and I. Tabas. 1991. Transforming growth factor-β1 inhibits scavenger receptor activity in THP-1 human macrophages. J. Biol. Chem. 266: 22866-22871.
45. Kaartinen, M., A. Penttila, and P. T. Kovanen. 1994. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Cirulation. 90: 1669-1678.
46. Zhou, X. H., G. Paulsson, S. Stemme, and G. K. Hansson. 1998. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J. Clin. Invest. 101: 1717-1725.
47. Platt, N., and S. Gordon. 1998. Scavenger receptors: diverse activities and promiscuous binding of polyanionic ligands. Chem. Biol. 5: R193-R203.
48. Yesner, L. M., H. Y. Huh, S. F. Pearce, and R. L. Silverstein. 1996. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler. Thromb. Vasc. Biol. 16: 1019-1025.
49. Calvo, D., D. Gomez-Coronado, Y. Suarez, M. A. Lasuncion, and M. A. Vega. 1998. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J. Lipid Res. 39: 777-788.
50. Yoshida, H., N. Kondratenko, S. Green, D. Steinberg, and O. Quehenberger. 1998. Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem. J. 334: 9-13.
51. Moriwaki, H., N. Kume, T., Sawamura, T. Aoyama, H. Hoshikawa, H. Ochi, E. Nishi, T. Masaki, and T. Kita. 1998. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler. Thromb. Vasc. Biol. 18: 1541-1547.
52. Fraser, I., D. Hughes, and S. Gordon. 1993. Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature. 364: 343-345.
53. Daugherty, A., S. C. Whitman, A. E. Block, and D. L. Rateri. 1999. The atherosclerosis susceptible strain of mouse, C57BL/6, lacks the adhesion and AcLDL receptor binding domain recognized by the antibody 2F8. Circulation. 100 (Suppl. 1 ): 1-751.
54. de Villiers, W. J. S., I. P. Fraser, D. A. Hughes, A. G. Doyle, and S. Gordon. 1994. Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function. J. Exp. Med. 180: 705-709.
55. de Villiers, W. J. S., I. P. Fraser, and S. Gordon. 1994. Cytokine and growth factor regulation of macrophage scavenger receptor expression and function. Immunol. Lett. 43: 73-79.
56. Mahley, R. W., T. L. Innerarity, M. S. Brown, Y. K. Ho, and J. L. Goldstein. 1980. Cholesteryl ester synthesis in macrophages: stimulation of β-very low density lipoproteins from cholesterol-fed animals of several species. J. Lipid Res. 21: 970-980.
57. Daugherty A., K. Oida, B. E. Sobel, and G. Schonfeld. 1988. Dependence of metabolic and structural heterogeneity of cholesterol ester-rich very low density lipoproteins on the duration of cholesterol feeding in rabbits. J. Clin. Invest . 82: 562-570.
58. Nishimura, N., M. HaradaShiba, S. Tajima, R. Sugano, T. Yamamura, Q. Z. Qiang, and A. Yamamoto. 1998. Acquisition of secretion of transforming growth factor-β 1 leads to autonomous suppression of scavenger receptor activity in a monocyle-macrophage cell line, THP-1. J. Biol. Chem. 273: 1562-1567.
59. Cyrus, T., J. L. Witztum, D. J. Rader, R. Tangirala, S. Fazio, M. F. Linton, and C. D. Funk. 1999. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apoE-deficient mice. J. Clin. Invest. 103: 1597-1604.